Gary Donovitz, MD, FACOG, is leading a health care revolution that focuses on optimizing and balancing bioidentical hormones for aging healthier and living happier by supporting heart, bone, brain, and sexual health, improved energy and clarity, and happiness for men and women of all ages.
After practicing as a Board-Certified OB/GYN for 30 years, Dr. Donovitz is now an internationally recognized leader, speaker, educator, and advocate of hormone optimization. He is the Founder of Biote, a leading innovator in subcutaneous hormone pellet therapy. He has personally performed more than 50,000 pellet insertions. The Biote state-of-the-art training facility hosts physicians, healthcare providers, and medical staff members monthly during the Biote Method learning and certification process. Over 5,700 providers in more than 2,600 clinics nationwide have successfully completed his rigorous curriculum and clinical training program. Collectively, these providers have performed more than 2.5 million pellet insertions to date.
His commitment to constantly raise the bar for health care extends beyond hormone therapy, as Dr. Donovitz has been at the forefront of developments in robotic surgery and has trained physicians across the country on how to perform operations using these advances in technology.
Dr. Donovitz received the Isadore Dyer award for best teaching resident while studying at Tulane University in New Orleans, Louisiana. He is a fellow of the American College of Obstetrics and Gynecology, a fellow of the Royal Society of Medicine, the Chairman of the International Consensus Committee on Testosterone Use in Women, and is the founder of the Institute for Hormonal Balance.
After monitoring outcomes for over 850,000 men and women who have undergone the Biote Method of hormone optimization, results continue to exceed expectations, with more than 96% of patients satisfied with their care.
Chief Executive Officer
Terry S. Weber leads the Biote team in advancing responsible access to scientifically-based, life-enhancing health therapies. Under her stewardship, Biote is accelerating and scaling its work as a collaborative clinical educator and patient advocate in an underserved market that’s been long overlooked by legacy life sciences companies, cementing Biote’s status as the leader in individualized hormone optimization.
As a Founding Board Member of the nonprofit PreventiveMedicine.org, Terry is convening stakeholders dedicated to building respectful dialogue around the integration of wellness expertise and clinical science to provide patients a more comprehensive continuum of patient options for hormone-related conditions, including menopause, diabetes, and others.
Forging and encouraging exponentially productive disruption is a through line in Terry’s career of executive leadership. As the former CEO of Amen Clinics and brainMD, Terry forged a path to leverage innovative clinical practices, establishing an exceptional roster of physicians, professional managers, and clinic directors and pushing her teams to change the way psychiatry is practiced to the benefit of patients.
Terry now serves on the board of the International Women’s Forum. She has also advised and supported the victims of investment fraud at Investor Advocates, and coordinated vocational training for immigrants and single parents at American Workshops.
Terry is a graduate of the New College of Florida and Purdue University. Connect with her on LinkedIn here or reach out to her within the ForbesWomen Forum.
Marc Beer brings more than 25 years of development and commercialization experience in biotechnology, pharmaceutical, device, and diagnostics and has served as CEO of Aegerion Pharmaceuticals, Inc. and ViaCell and as a member of the Erytech Pharma Board of Directors.
A member of the Miami University Business Advisory Council, Mark previously served as a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council.
Marc has led several companies through significant capital raises and public offerings, including Renovia, LumeNXT Inc., Origami Surgical, Liftique, and Minerva Neurosciences Inc. His extensive experience as a Founder, CEO, and Chairman in numerous health-related companies makes him an ideal contributor to support Biote’s growth initiatives.
At Vector Medical Group, Dana Jacoby leads a team of expert consultants. Her expertise spans numerous medical specialties including gastroenterology, dermatology, orthopedics, oncology, dermatology, and retina. Her consulting work is informed by market data, measurement and analytics, strategy design, implementation, and technology innovation. She has personally consulted with over 75% of all urology practices in the US.
As owner of several companies, Dana has overseen multiple mergers and private equity transactions. Additionally, she’s consulted for up to $1 billion in mergers and acquisitions, making her one of the most sought-after healthcare specialists in the US.
Dana has worked for individual providers as well as large corporate healthcare companies including General Electric Healthcare and Johnson & Johnson. At Allergen, a global Pharmaceutical Company, she helped launch Botox in Asia.
In her spare time, Dana is an avid runner and Boston Marathon qualifier and has run 68 marathons, including one in every US state and on every continent except Antarctica.
S. Mark Cone, MD, FACOG
Dr. Mark Cone is currently on staff at the Woman’s Hospital of Texas and St. Luke’s Episcopal Hospital and is a clinical instructor in the Department of Obstetrics and Gynecology at Baylor College of Medicine. He practices both obstetrics and gynecology and has experience with general obstetrics, high-risk obstetrics, twins, gynecologic surgery, minimally invasive surgery, and infertility.
Dr. Cone is President of the executive board at OBGYN Medical Center Associates, President of Privia Medical Group – Gulf Coast Texas, and President and Chairman of the Board of Directors of Southwest Women’s Health Alliance.
As an experienced Chief Executive Officer who has a demonstrated history of success in physician group management and value-based care, he offers valuable leadership knowledge to the Biote leadership team.
Dr. Cone is a graduate of Klein High School, Texas A&M University, and Baylor College of Medicine. He did his residency training at Baylor College of Medicine and has worked in the Texas Medical Center since 1980.